DARE · Dare Bioscience Inc
United States · RS rating 12 · As of 2026-10-14
| Price | 0.73 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 67 / 3 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 17 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +4.8% |
| Sales growth Q/Q | +45155.3% |
| Distance from 52-week high | +77.7% |
| Market cap (USD) | $30.9M |